Press Releases

AdvaMed Receives RAPS Accreditation for Medical Device Submissions Workshop Series (February 2026 in Washington, D.C.)

WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medical technology innovators, announced that its Medical Device Submissions Workshop Series (February 23-27 in Washington, D.C.) has been officially approved for RAC recertification credits by the Regulatory Affairs Professionals Society (RAPS).

As a RAPS Approved Provider, AdvaMed is authorized to offer accredited educational programming that meets the RAC recertification requirements, further reinforcing the quality, rigor, and regulatory relevance of its professional development offerings.

The approval applies to AdvaMed’s in-depth, FDA-informed workshops designed to support regulatory professionals across the full medical device submission lifecycle, including:

Each workshop features expert instruction from FDA speakers and experienced regulatory leaders, providing participants with practical insights, real-world applications, and direct engagement with the regulatory process.

Provider Statement
AdvaMed is a RAPS Approved Provider. This educational program meets the RAC recertification requirements to maintain the credential. For more information about the RAC, visit www.raps.org/rac.

Credit Statement
This program has been approved for up to the number of RAC recertification credits listed for each course.

As an annual RAPS Approved Provider, AdvaMed and its accredited courses will be listed in the RAPS Approved Provider Directory, with direct links to AdvaMed’s course offerings to help regulatory professionals easily identify and access approved education opportunities.

AdvaMed’s Medical Device Submissions Workshop Series is part of the association’s broader commitment to advancing regulatory excellence, professional development, and innovation across the medtech ecosystem.

For more information and to register for upcoming workshops, visit AdvaMed.org/events.

### 

Call to Action Heading…

Call to Action Description…